Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of In Vivo Candida albicans Vascular Catheter Infection and Ex Vivo Candida auris Skin Colonization
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.00081-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Sarah R Beattie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Candidiasis, Vascular Access Devices. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases, National Science Foundation.
Abstract (Originalsprache)
New antifungal therapies are needed for both systemic, invasive infections in addition to superficial infections of mucosal and skin surfaces as well as biofilms associated with medical devices. The resistance of biofilm and biofilm-like growth phases of fungi contributes to the poor efficacy of systemic therapies to nonsystemic infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
- Department of Chemistry and Biochemistry, Northern Illinois University, DeKalb, Illinois, USA.
- Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
- Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
- Department of Microbiology/Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
- Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
ORCID-Profile: Jeniel E Nett, David R Andes, Damian J Krysan
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- National Science Foundation
Zitieren
APA
Beattie, S. R., Esan, T., Zarnowski, R., Eix, E., Nett, J. E., Andes, D. R., Hagen, T., & Krysan, D. J. (2023). Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of In Vivo Candida albicans Vascular Catheter Infection and Ex Vivo Candida auris Skin Colonization. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00081-23
Vancouver
Beattie SR, Esan T, Zarnowski R, Eix E, Nett JE, Andes DR, et al. Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of In Vivo Candida albicans Vascular Catheter Infection and Ex Vivo Candida auris Skin Colonization. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00081-23
BibTeX
@article{Beattie2023,
author = {Beattie, Sarah R and Esan, Taiwo and Zarnowski, Robert and Eix, Emily and Nett, Jeniel E and Andes, David R and Hagen, Timothy and Krysan, Damian J},
title = {Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of In Vivo Candida albicans Vascular Catheter Infection and Ex Vivo Candida auris Skin Colonization},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.00081-23}
}
EUVIMED